Laminar Pharma is a pioneering biopharmaceutical company that focuses on the discovery, rational design and development of a new generation of medicines that act through the innovative therapeutic strategy known as “Membrane-Lipid Therapy” (MLT). Laminar Pharma arose in 2006 as an academic spin-off to commercially develop new scientific know-how and applications generated by leading scientists at the University of the Balearic Islands (UIB) in Mallorca, Spain, headed by Prof. Pablo V. Escriba.
Laminar Pharma aims to develop next-generation medicines, nutraceutical and cosmetic products based on the novel Membrane-Lipid Therapy (MLT) strategy, which targets membrane lipids and/or the structures they form, rather than directly targeting specific cellular proteins. MLT-based drugs specifically interact with and modulate the activity of key signal-transduction peripheral proteins involved in the pathogeny of serious diseases like cancer, CNS, inflammatory or metabolic diseases.
Innovative MLT-based drugs will soon become reference treatments worldwide for serious diseases with important medical needs unmet, such as glioblastoma and other aggressive cancer malignancies, as well as neuro-degenerative, metabolic, cardiovascular or inflammatory diseases. These novel drugs will provide a safe and efficacious therapeutic alternative that will bring dramatic improvements in the clinical outcome and in the quality of life for an important number of patients with these pathologies.
Company Details
- Employees
- 39
- Founded
- -
- Address
- Ctra Valldemossa Km. 7,4, Parcbit. Edif. 17 2º Piso
- Phone
- +34 971 43 98 86
- in****@****rma.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- laminarpharma.com
- Keywords
- Design, research and development of innovative molecules based on the novel therapeutic approach, the Membrane Lipid Therapy (MLT).
- HQ
- Palma de Mallorca, Illes Balears
Laminar Pharma Questions
Laminar Pharma's helpline number is +34 971 43 98 86
Laminar Pharma's website is laminarpharma.com
Laminar Pharma's LinkedIn profile is https://www.linkedin.com/company/laminarpharma
Laminar Pharma has
39 employees.
View email and phone details for 39
employees at Laminar Pharma.
Laminar Pharma's industry is
Biotechnology Research
Laminar Pharma's top competitors are
Trimerbody Pharma,
Pharmamar,
Neurofix Pharma S.a.,
Labo'life España,
Roams,
Bioib,
Circe Health Science,
Telum Therapeutics,
Neurologyca Science & Marketing,
Ikan Biotech.
Laminar Pharma's support email address is info@laminarpharma.com
Laminar Pharma's categories are Biotechnology Research
Laminar Pharma's founding year is 2006
